ArticleSurgical endoscopy2026
Robot‑assisted versus open radical nephrectomy and venous tumor thrombectomy: perioperative and oncologic outcomes-an inverse probability of treatment weighting analysis.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundOpen radical nephrectomy and venous thrombectomy (ORN‑VT) is standard for renal cell carcinoma with tumor thrombus (RCC-TT), but robot‑assisted radical nephrectomy and venous thrombectomy (RARN‑VT) may improve outcomes. We used inverse probability of treatment weighting (IPTW) to compare perioperative and oncologic results.
methodsThis retrospective cohort study included 418 patients (239 RARN‑VT, 179 ORN‑VT) treated at a high‑volume center between 2014 and 2025. IPTW balanced 19 baseline covariates using the covariate balancing propensity score method. Weighted regression was used for perioperative outcomes, and weighted Cox regression for progression‑free survival (PFS) and overall survival (OS). Propensity score matching (PSM) and an overlapping time‑period analysis (2020-2025) were performed as sensitivity analyses.
resultsAfter IPTW, all covariates were well balanced. RARN‑VT was associated with significantly shorter operation time (β = - 91.63), less estimated blood loss (β = - 885.05), lower transfusion volume (β = - 561.32), shorter length of stay (β = - 2.79), and reduced odds of blood transfusion (OR = 0.26) and any postoperative complication (OR = 0.44) (all P < 0.001). PFS showed no significant difference between approaches (log‑rank P > 0.05). Both sensitivity analyses confirmed the association between RARN‑VT and better perioperative outcomes.
conclusionsFor RCC and TT patients, RARN‑VT was associated with improved perioperative outcomes. Prospective or randomized studies are warranted to further explore the oncological equivalence or superiority of the robotic approach.
Indexed as
Identifiers
42618819What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.